Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
VT3989
i
Other names:
VT3989
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Vivace Therap
Drug class:
TEAD inhibitor
Related drugs:
‹
VT-104 (2)
IAG933 (1)
TY-0584 (1)
BGI-9004 (0)
BPI-460372 (0)
SPR1-0117 (0)
Undisclosed YAP/TAZ-TEAD inhibitor (0)
VT-104 (2)
IAG933 (1)
TY-0584 (1)
BGI-9004 (0)
BPI-460372 (0)
SPR1-0117 (0)
Undisclosed YAP/TAZ-TEAD inhibitor (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR mutation
Non Small Cell Lung Cancer
EGFR mutation
Non Small Cell Lung Cancer
osimertinib + VT3989
Sensitive: D – Preclinical
osimertinib + VT3989
Sensitive
:
D
osimertinib + VT3989
Sensitive: D – Preclinical
osimertinib + VT3989
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login